Vitamin D deficiency is not good for you

Diabetes Care

Volumn 34, Issue 5, 2011, Pages 1245-1246

  Mathieu, Chantal ^a   Van Der Schueren, Bart J ^b  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b Columbia University College of Physicians and Surgeons ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; PARICALCITOL; VITAMIN D; VITAMIN D DERIVATIVE;

CARDIOVASCULAR RISK; CHRONIC KIDNEY FAILURE; DISEASE ASSOCIATION; EDITORIAL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LIQUID CHROMATOGRAPHY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; SUN EXPOSURE; TANDEM MASS SPECTROMETRY; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

ADOLESCENT; ADULT; ALBUMINURIA; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; MALE; VITAMIN D; VITAMIN D DEFICIENCY; YOUNG ADULT;

EID: 79956083932     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc11-0307     Document Type: Editorial

References (16)

1. Joergensen C, Hovind P, Schmedes A, et al. Vitamin D levels, microvascular complications, and mortality in type 1 diabetes. Diabetes Care 2011;34:1081-1085
2. Melamed ML, Michos ED, Post W, Astor B. 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med 2008;168:1629-1637
3. Joergensen C, Gall MA, Schmedes A, Tarnow L, Parving HH, Rossing P. Vitamin D levels and mortality in type 2 diabetes. Diabetes Care 2010;33:2238-2243
4. Doorenbos CR, van den Born J, Navis G, de Borst MH. Possible renoprotection by vitamin D in chronic renal disease: beyond mineral metabolism. Nat Rev Nephrol 2009;5:691-700
5. Giulietti A, Gysemans C, Stoffels K, et al. Vitamin D deficiency in early life accelerates type 1 diabetes in non-obese diabetic mice. Diabetologia 2004;47:451-462 (Pubitemid 38491241)
6. Wallace AM, Gibson S, de la Hunty A, Lamberg-Allardt C, Ashwell M. Measurement of 25-hydroxyvitamin D in the clinical laboratory: current procedures, performance characteristics and limitations. Steroids 2010;75:477-488
7. Ross AC, Manson JE, Abrams SA, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 2011; 96:53-58
8. Alborzi P, Patel NA, Peterson C, et al. Paricalcitol reduces albuminuria and in- flammation in chronic kidney disease: a randomized double-blind pilot trial. Hypertension 2008;52:249-255
9. de Zeeuw D, Agarwal R, Amdahl M, et al. Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial. Lancet 2010;376:1543-1551
10. Holick MF. Vitamin D: its role in cancer prevention and treatment. Prog Biophys Mol Biol 2006;92:49-59 (Pubitemid 43831958)
11. Stolzenberg-Solomon RZ, Jacobs EJ, Arslan AA, et al. Circulating 25-hydroxyvitamin D and risk of pancreatic cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol 2010;172:81-93
12. Giovannucci E. Vitamin D and cancer incidence in the Harvard cohorts. Ann Epidemiol 2009;19:84-88
13. Reichrath J. Skin cancer prevention and UV-protection: how to avoid vitamin D-deficiency? Br J Dermatol 2009;161(Suppl. 3):54-60
14. Janssens W, Bouillon R, Claes B, et al. Vitamin D deficiency is highly prevalent in COPD and correlates with variants in the vitamin D-binding gene. Thorax 2010;65: 215-220
15. Rodríguez-Rodríguez E, Navia B, López- Sobaler AM, Ortega RM. Vitamin D in overweight/obese women and its relationship with dietetic and anthropometric variables. Obesity (Silver Spring) 2009;17: 778-782
16. Fish E, Beverstein G, Olson D, Reinhardt S, Garren M, Gould J. Vitamin D status of morbidly obese bariatric surgery patients. J Surg Res 2010;164:198-202